Founded in 1995, Shandong GRED Medical Co., Ltd. is located in the beautiful coastal city – Weihai, Shandong. With the registered capital of 37 million Yuan and total assets of more than 100 million Yuan, the company occupies the land of more than 4,000 square meters, has Grade 100,000 GMP standard cleaning room of more than 4000 square meters and more than 240 employees, including more than 60 intermediate and senior technicians, and is a high-tech company specializing in scientific research, production and sales service.
The company’s business scope covers the neurosurgery, obstetrics and gynecology, ICU and other clinical departments, and the main products include drainage devices and intracranial pressure monitoring supplies and equipments for neurology department, newborn care series of products for obstetrics and gynecology department, as well as interventional series of products for ICU. The products have been sold to more than thirty provinces, cities and autonomous regions nationwide, and the company has more than 1,900 channel distributors and more than 4,500 end clients.
The company has the solid technology research and development strength and product innovation advantages, and owns the Provincial Technical Center, Weihai Research and Development Center for Neurosurgery Devices, and Engineering and Technical Research and Development Center. With the technology research and development as well as clinical practices for more than 20 years, the company developed more than 30 patents independently, and participated in preparation of External Drainage Collection Device for Cranial Puncture, External Drainage Collection Device for Lumbar Puncture Cerebrospinal Fluid, Cranial External Drainage Catheter and other industry standards. The continuous external drainage system for lumbar cistern filled the gap in the domestic market; the disposable external drainage device for craniocerebral was elected as the recommended product for use by the National “Twelfth Five-year Plan” Science and Technology Program Research Group; the market share of newborn care series of products has been ranked top in China for consecutive years.
Based on the quality policy of “legitimate operation, and considering quality as the life; maintaining efficient, and customer-focused”, the company obtained ISO13485 Quality System Certification and ISO9001 Quality System Certification of medical device industry, and implemented the modern production and management strictly in accordance with the requirements of the quality management system.
The company was listed in New OTC in January 2014, and now is moving toward a broader field of medical technology.
The life is cared by the science and technology, and the dream is protected by the health. Focusing on science, technology and innovation is only for better changes and possibility, and GRED wishes to create a trustworthy future of health.